Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)
- Previous Close
33.44 - Open
33.50 - Bid 32.93 x --
- Ask 32.96 x --
- Day's Range
32.81 - 33.60 - 52 Week Range
28.11 - 46.84 - Volume
1,955,339 - Avg. Volume
3,516,345 - Market Cap (intraday)
5.818B - Beta (5Y Monthly) --
- PE Ratio (TTM)
25.95 - EPS (TTM)
1.27 - Earnings Date --
- Forward Dividend & Yield 0.58 (1.73%)
- Ex-Dividend Date Jul 1, 2024
- 1y Target Est
--
Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry, and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.
www.eastonpharma.cnRecent News: 688513.SS
View MorePerformance Overview: 688513.SS
Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688513.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688513.SS
View MoreValuation Measures
Market Cap
5.90B
Enterprise Value
4.55B
Trailing P/E
26.33
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.39
Price/Book (mrq)
2.14
Enterprise Value/Revenue
3.40
Enterprise Value/EBITDA
19.10
Financial Highlights
Profitability and Income Statement
Profit Margin
16.70%
Return on Assets (ttm)
3.71%
Return on Equity (ttm)
8.31%
Revenue (ttm)
1.34B
Net Income Avi to Common (ttm)
223.81M
Diluted EPS (ttm)
1.27
Balance Sheet and Cash Flow
Total Cash (mrq)
1.49B
Total Debt/Equity (mrq)
5.18%
Levered Free Cash Flow (ttm)
15.83M